Chinese health biotech and the billion-patient market

被引：62

作者：

Frew, Sarah E. ^{[1
,2
]}

Sammut, Stephen M. ^{[3
,4
]}

Shore, Alysha F. ^{[1
,2
]}

Ramjist, Joshua K. ^{[1
,2
]}

Al-Bader, Sara ^{[1
,2
]}

Rezaie, Rahim ^{[1
,2
]}

Daar, Abdallah S. ^{[1
,2
]}

Singer, Peter A. ^{[1
,2
]}

机构：

[1] Univ Hlth Network, McLaughlin Rotman Ctr Global Hlth, Toronto, ON M5G 1L7, Canada

[2] Univ Toronto, MaRS Ctr, Toronto, ON M5G 1L7, Canada

[3] Univ Penn, Philadelphia, PA 19104 USA

[4] Burrill & Co, Embarcadero Ctr 1, San Francisco, CA 94111 USA

来源：

NATURE BIOTECHNOLOGY | 2008年 / 26卷 / 01期

关键词：

D O I：

10.1038/nbt0108-37

中图分类号：

Q81 [生物工程学（生物技术）]; Q93 [微生物学];

学科分类号：

071005 ; 0836 ; 090102 ; 100705 ;

摘要：

Chinese government support and 'sea turtles' are spurring the sector, but investors lack exits.

引用

页码：37 / 53

页数：17

共 19 条

[11]

LI Z, 2005, INNOVATION DEV COUNT, P37

[12] Hepatitis B in China [J].

Liu, Jie ;

Fan, Daiming .

LANCET, 2007, 369 (9573) :1582-1583

[13] Can China bring its own pipeline to the market? [J].

Louët, S .

NATURE BIOTECHNOLOGY, 2004, 22 (12) :1497-1499

[14] China approves first gene therapy [J].

Pearson, S ;

Jia, HP ;

Kandachi, K .

NATURE BIOTECHNOLOGY, 2004, 22 (01) :3-4

[15]

*UNDP, 2006, DEV REP 2006 SCARC P

[16]

*US DEP HHS, 2003, CHALL GLOB AG

[17]

Yu Zailin, 2006, Biotechnology Journal, V1, P1253, DOI 10.1002/biot.200600086

[18] Competing for talent: China's strategies to reverse the brain drain [J].

Zweig, David .

INTERNATIONAL LABOUR REVIEW, 2006, 145 (1-2) :65-+

[19]

2004, NAT BIOTECHNOL S, V22, pDC1

← 1 2 →